<DOC>
	<DOC>NCT02398539</DOC>
	<brief_summary>This protocol describes a randomized, two arm clinical trial comparing two topical treatments in patients with hypergranulation tissue at gastrostomy tube sites. The subjects are randomized to either group 1or group 2 treatments: Maximum duration of therapy is 4 weeks. However, the therapy may be discontinued anytime at the discretion of the investigator or if there is resolution of the of the hypergranulation tissue.</brief_summary>
	<brief_title>Silver Nitrate Application and Topical Corticosteroids for Hypergranulation Tissue</brief_title>
	<detailed_description />
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<mesh_term>Silver Nitrate</mesh_term>
	<criteria>1. Pediatric patients &lt;18 2. Evaluated for hypergranulation at the Gtube site 3. Inpatient and outpatient Children not meeting the above criteia</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>